Recently Awarded Research Grants
Project Title:
Project Principal Investigator/s:
Lilliana M. Sanchez
Project Co-Investigator/s:
Ben Clark (Sponsor)
Funding Agency:
National Institute on Alcohol Abuse and Alcoholism
Amount Awarded:
$108,588
Period of Performance:
10/2022 - 09/2025
Goals and Aims of Study
Fetal Alcohol Spectrum Disorders involve morphologic and neurobiological abnormalities in offspring subjected to prenatal alcohol exposure. While learning and memory deficits have been well characterized after prenatal alcohol exposure, few studies have determined the circuit or systems level mechanisms. A complete understanding of memory deficits after prenatal alcohol exposure is needed to ultimately identify treatments that may mitigate impacts later in life. In our previous work, we determined that rats with moderate prenatal alcohol exposure are significantly impaired in learning associations between an object and its spatial location. Further, disruption to the hippocampus impairs object-place associations and object-place learning and memory is critically dependent on synchronized rhythmic activity of hippocampal cell populations. In two aims, we will test the hypotheses that impaired learning and memory after moderate prenatal alcohol exposure is associated with uncoupling of brain activity oscillations within the hippocampal formation and that these alterations in hippocampal rhythmic activity are associated with impairments in learning and remembering the locsation of objects in the environment.How this Research Will Benefit Society
Fetal Alcohol Spectrum Disorders are characterized by cognitive abnormalities in offspring exposed to alcohol during pregnancy. One of the most common cognitive deficits in Fetal Alcohol Spectrum Disorders involve impaired learning and memory and altered hippocampal function. A complete understanding of the neural bases of learning and memory deficits in Fetal Alcohol Spectrum Disorders is needed to ultimately identify treatments that may mitigate impacts later in life. The aims of this proposal will significantly advance our understanding of the neurobiological mechanisms of learning and memory deficits after moderate prenatal alcohol exposure.Project Title:
Project Principal Investigator/s:
Ben Clark
Project Co-Investigator/s:
Aaron Wilber (Florida State University)
Funding Agency:
National Institute on Alcohol Abuse and Alcoholism
Amount Awarded:
1,586,632 -over five years
Period of Performance:
02/2022 - 01/2027
Goals and Aims of Study
Fetal Alcohol Spectrum Disorders are a set of major morphological, neurobiological, and cognitive abnormalities in offspring exposed to alcohol in utero. A common cognitive manifestation of alcohol exposure during neural development in humans, and in animal models of prenatal alcohol exposure, are deficits in spatial learning and memory. In moderate PAE (BECs ~60-80mg/dl), spatial deficits are marked by an inability to accurately discriminate between spatial locations or retain previously learned spatial relationships. Such deficits may ultimately reflect alterations in the neural systems and circuits involved in encoding and retaining learned spatial information. The long-term goal of our research program is to identify the neurobiological mechanisms of spatial learning and memory impairments after moderate prenatal alcohol exposure.How this Research Will Benefit Society
Fetal Alcohol Spectrum Disorders are a set of major morphological, neurobiological, and cognitive abnormalities in offspring exposed to alcohol in utero. Deficits in spatial learning and memory are one of the most common cognitive abnormalities reported in Fetal Alcohol Spectrum Disorders. Further investigation of the neurobiological mechanisms underlying spatial learning and memory impairments is critically important for the development of precise diagnostic tools and therapeutic interventions to help manage or reverse disordered brain states.Project Title:
Project Principal Investigator/s:
Katie Witkiewitz and Matthew Pearson
Project Co-Investigator/s:
Margo Hurlocker, Kamilla Venner, Angel Vasquez, Brady Horn, Scott Tonigan
Funding Agency:
National Institute on Drug Abuse
Amount Awarded:
$10.6 million
Period of Performance:
10/2021 - 09/2026
Goals and Aims of Study
The center, Integrative Management of Chronic Pain and Opioid use disorder for Whole Recovery (UNM IMPOWR Center), is funded as part of the NIH HEAL Initiative and will implement two major studies and will also create infrastructure for training, pilot research projects, and community-based participatory research approaches to targeting chronic pain and opioid use disorder. Specific research projects will test the effectiveness, mechanisms, and implementation of an integrated psychosocial treatment for chronic pain and opioid use disorder among individuals receiving buprenorphine from outpatient opioid use disorder treatment clinics, and will use community-based participatory research methods to develop a culturally-centered implementation intervention for screening and brief intervention of chronic pain and opioid use disorder among American Indian/Alaska Native patients in primary care settings. The UNM IMPOWR Center is committed to data harmonization, sharing of study resources, and provider training to enhance the reach, effectiveness, adoption, implementation, and maintenance of evidence-based treatments for chronic pain and OUD. The IMPOWR Center will also provide valuable training opportunity for postdoctoral fellows, graduate students, and undergraduate students at UNM. All projects by the UNM IMPOWR Center are designed to rapidly move from evaluating how well these treatments work to getting them implemented in the real world.How this Research Will Benefit Society
Chronic pain and opioid use disorder are major public health problems. The University of New Mexico (UNM) Integrative Management of chronic Pain and Opioid use disorder for Whole Recovery (IMPOWR) Center will take an integrated and holistic approach to improving the lives of individuals with chronic pain and opioid use disorder via tailored intervention approaches to meet the needs of diverse individuals in diverse communities. Through the projects of the UNM IMPOWR Center, we will explicitly target increasing quality of life and engagement in valued activities, the cultural centering of interventions to meet the needs of diverse patient populations, and reducing stigma of chronic pain and opioid use disorder. The UNM IMPOWR Center will directly benefit individuals in New Mexico, Michigan and Minnesota, and other sites across the country serving American Indian and Alaska Native communities.Project Title:
Project Principal Investigator/s:
Katie Witkiewitz
Project Co-Investigator/s:
Theresa Moyers
Funding Agency:
Kaiser Foundation Research Institute--NIH
Amount Awarded:
187,273
Period of Performance:
06/2020 - 05/2024
Goals and Aims of Study
This study will test an innovative model of care management—provided by a nurse over the telephone—for primary care patients with opioid use disorder and depression in Washington state and Indiana. The trial will test whether patients who receive nurse care management are more likely to receive medication treatment for opioid use disorder, and more likely to have clinically significant reduction in symptoms of depression, over the following 12 months.How this Research Will Benefit Society
Most people are not receiving the best care for opioid use disorder and depression. But effective treatments do exist and can be prescribed in a primary care office. This research will proactively engage patients in these treatments and provide troubleshooting to help them stay engaged. This project is really exciting for the novelty of doing proactive direct to patient care of an intervention that is intended to improve patient care within a health care system. It is interdisciplinary and collaborative and relies on technology, psychology, psychiatry, primary care, family medicine, and health care systems models of care. Taking a whole team collaborative approach to address a complex problem is incredibly challenging and is likely to be highly rewarding by directly impacting patient’s lives.